Clinical Imaging
Excellence for
Drug Development.
Purpose-built imaging center equipped with GE 1.5T 30X MRI, 128-Slice CT, DEXA body composition scanning, and advanced ultrasound — supporting pharmaceutical clinical trials from NASH/NAFLD to oncology and cardiac safety studies.
MRI, CT, and Ultrasound under one roof
Rapid turnaround for time-sensitive trials
Full regulatory documentation and audit readiness
From NASH to oncology, cardiac to neurological
Purpose-Built for Pharmaceutical Research
Our imaging center is equipped with the latest clinical‑grade systems, certified and calibrated for pharmaceutical trial data collection and regulatory compliance.
GE SIGNA 1.5T MRI
with MR 30 Software & AIR Recon DL
- 1.5 Tesla with 30X acceleration technology
- AIR Recon DL for 3.0T-level image quality
- MRI-PDFF for quantitative liver fat fraction
- MR Elastography (MRE) for fibrosis staging
- Cardiac cine with Sonic DL reconstruction
- Diffusion-weighted imaging for oncology
- Multi-site standardization via AIR x
128-Slice Multi-Detector CT
High-Speed Precision Scanning
- Sub-millimeter slice resolution
- Full abdomen scan in under 12 seconds
- Low-dose protocols for longitudinal studies
- CT coronary angiography for cardiac safety
- Contrast perfusion studies for oncology
- Hepatocellular carcinoma (HCC) screening
- Calcium scoring and vascular assessment
DEXA Body Composition
Gold Standard Precision Measurement
- Dual-energy X-ray absorptiometry technology
- Precise body fat % and lean mass measurement
- Bone mineral density (BMD) assessment
- Visceral adipose tissue (VAT) quantification
- Segmental body composition analysis
- Low-dose radiation exposure
- Year-over-year trend tracking capability
Clinical Ultrasound Suite
Elastography & Doppler Capabilities
- High-frequency linear and convex transducers
- Shear wave elastography (SWE) for liver fibrosis
- Vibration-controlled transient elastography (VCTE)
- Color and power Doppler flow imaging
- Contrast-enhanced ultrasound (CEUS)
- Real-time biopsy guidance capability
- Thyroid, renal, and hepatic assessments
Pharmaceutical Study Protocols
Specialized imaging protocols designed for pharmaceutical clinical trials across key therapeutic areas, with standardized acquisition parameters for multi-site reproducibility.
Fatty Liver Disease (NASH/MASLD)
Non-invasive quantification of hepatic steatosis and fibrosis staging for NASH/MASLD drug development trials. MRI-PDFF is now recognized by the FDA and EMA as equivalent to biopsy for quantifying liver fat.
Imaging Protocols
Primary Imaging Endpoints
Why Pharma Companies Choose Trinity
From protocol design to final data delivery, we provide end‑to‑end imaging support built for the rigorous demands of pharmaceutical clinical trials.
Rapid Turnaround
24–48 hour preliminary results with full audit-ready reports within 5 business days. Expedited reads available for urgent protocols.
GCP & FDA Compliance
Full Good Clinical Practice documentation, 21 CFR Part 11 compliant data handling, and regulatory-ready imaging reports.
Dedicated Pharma Liaison
A specialized pharmaceutical imaging coordinator manages your trial from protocol design through final data delivery.
HIPAA-Compliant Data
Encrypted DICOM transfer, secure cloud storage, and de‑identified datasets delivered via compliant file‑sharing platforms.
Flexible Scheduling
Extended hours and weekend availability for clinical trial participants. Dedicated time slots to minimize patient wait times.
Quality Metrics & Monitoring
Real‑time study dashboards, automated quality control checks, and standardized acquisition parameters across all scans.
Multi‑Site Standardization
AIR x and AIR Recon DL ensure consistent image quality. We provide phantom calibration data for cross‑site validation.
AI‑Enhanced Analysis
FDA‑cleared AI tools for automated lesion segmentation, volumetric analysis, and quantitative biomarker extraction.
Seamless Trial Integration
From initial consultation to final data delivery, our streamlined process ensures your clinical trial imaging runs smoothly.
Protocol Consultation
Our pharmaceutical imaging team reviews your study requirements, therapeutic area, and regulatory needs to design a customized imaging protocol.
Site Qualification
We provide equipment specifications, phantom calibration data, and compliance documentation for your sponsor and CRO site qualification process.
Patient Imaging
Dedicated scheduling, standardized acquisition, and real‑time quality checks ensure every scan meets your protocol requirements.
Data Delivery
Audit‑ready reports, de‑identified DICOM datasets, and quantitative biomarker analysis delivered via secure, compliant platforms.
Ready to Advance Your Clinical Research?
Whether you are planning a Phase 2 NASH trial or need cardiac safety imaging for a new compound, our team is ready to design a customized imaging protocol for your study.